BioSpace News Archive

Drug Development

Glenmark to Commence New Phase 3 Clinical Trial on Combination of Two Anti-viral Drugs Favipiravir and Umifenovir in Hospitalized Patients of Moderate COVID-19 in India

Glenmark Pharmaceuticals, a global pharmaceutical company, announced a new randomized, open-label study to test the combined efficacy of two antiviral drugs Favipiravir and Umifenovir as a potential COVID-19 treatment strategy.

May 26, 2020
·
2 min read
Biotech Beach

MEI Pharma to Host Investor and Analyst Video Webcast Following ASCO20 Virtual Scientific Program

MEI Pharma, Inc. announced that it will host an investor and analyst video webcast event on Tuesday, June 2nd, 2020 at 8:00 AM ET following the ASCO20 Virtual Scientific Program.

May 26, 2020
·
3 min read
BioMidwest

Clene Nanomedicine Announces Over 50% of Subjects Randomized in RESCUE-ALS Clinical Trial for Treatment of Amyotrophic Lateral Sclerosis (ALS) with Lead Nanocatalytic Therapeutic, CNM-Au8

Clene Nanomedicine, Inc., a clinical-stage biopharmaceutical company, announced its Australian subsidiary has completed over 50% of participant randomization in the Phase 2 RESCUE-ALS study with its lead nanocatalytic therapy, CNM-Au8, for the treatment of Amyotrophic Lateral Sclerosis.

May 26, 2020
·
4 min read
Business

Thermo Fisher Scientific Recognizes Tandem Mass Tag Grant Award Winners

International competition rewards top proteomics researchers for outstanding innovation and impact

May 26, 2020
·
2 min read
Biotech Bay

Next-Generation Analytical Software Strengthens Data Exploration

Thermo Scientific software suite expands capabilities in sample analysis with enhanced flexibility, reliability and customization

May 26, 2020
·
6 min read
Biotech Bay

New, Versatile High-Resolution Mass Spectrometer Expands Market-leading Thermo Scientific Orbitrap Platform

Thermo Scientific Orbitrap Exploris 240 mass spectrometer drives discovery and identification with quantitative precision and accuracy to meet customers’ specific analytical requirements

May 26, 2020
·
6 min read
Pharm Country

PTC Therapeutics to Present at the Jefferies 2020 Virtual Healthcare Conference

PTC Therapeutics, Inc. announced that management will present a company overview at the Jefferies Virtual Healthcare Conference on Tuesday, June 2nd at 1:00 p.m. ET.

May 26, 2020
·
1 min read
BioMidwest

Apotex Corp. Donates Critical Medicines in the Fight Against COVID-19

Apotex Corp. announced that it has donated much needed medicines in the fight against COVID-19 to U.S. Department of Health and Human Services.

May 26, 2020
·
1 min read
Pharm Country

Daiichi Sankyo Launches ENHERTU® in Japan for Patients with HER2 Positive Unresectable or Metastatic Breast Cancer

ENHERTU is the second innovative oncology medicine to be launched in Japan from the oncology pipeline of Daiichi Sankyo in the past year

May 26, 2020
·
13 min read
Policy

Qurient Announces U.S. FDA Clearance of IND Application for Q702, a Novel Cancer Immunotherapy

Qurient Co. Ltd., a clinical stage biotech company in Korea, announced that the U.S. Food and Drug Administration has cleared its investigational new drug application for Q702, orally available immuno-oncology therapeutic small molecule targeting Axl, Mer and CSF1 receptor tyrosine kinases.

May 26, 2020
·
4 min read